ATRIUM THERAPEUTICS INC (RNA:NASDAQ)
$10.36 0.01 (0.0966%)
Analysed ATRIUM THERAPEUTICS INC (RNA:NASDAQ) News Sources
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
14-07-2026
yahoo.com
Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls
06-08-2026
yahoo.com
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
13-08-2026
yahoo.com
Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?
28-08-2026
yahoo.com
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21-04-2026
yahoo.com
Here's Why We're Not Too Worried About Atrium Therapeutics' (NASDAQ:RNA) Cash Burn Situation
28-05-2026
yahoo.com
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20-07-2026
yahoo.com
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
13-08-2026
yahoo.com
Atrium Therapeutics to Participate in Upcoming Investor Conferences
02-09-2026
yahoo.com
Wall Street Money Is Leaving Just As Atrium’s (RNA) Pipeline Turns Real
06-09-2026
yahoo.com
What is the current price of ATRIUM THERAPEUTICS INC (RNA:NASDAQ)?
The current price of ATRIUM THERAPEUTICS INC (RNA:NASDAQ) is $10.36.
ATRIUM THERAPEUTICS INC (RNA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ATRIUM THERAPEUTICS INC (RNA:NASDAQ) since the previous trading day is $0.01.
ATRIUM THERAPEUTICS INC (RNA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ATRIUM THERAPEUTICS INC (RNA:NASDAQ) since the previous trading day is 0.0966%.
What is the most recent average sentiment score for ATRIUM THERAPEUTICS INC (RNA:NASDAQ)?
The most recent average sentiment score for ATRIUM THERAPEUTICS INC (RNA:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for ATRIUM THERAPEUTICS INC (RNA:NASDAQ)?
The most recent sentiment for ATRIUM THERAPEUTICS INC (RNA:NASDAQ) is .
SEC-8K** Filing Available For ATRIUM THERAPEUTICS INC (RNA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.